Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,038 | -13,986 | -15,612 | -16,134 | -6,026 |
| Depreciation Amortization | 608 | 984 | 1,767 | 7,271 | 1,666 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -107 |
| Accounts receivable | -762 | 184 | 592 | -40 | -1,119 |
| Other Working Capital | -1,446 | -3,508 | 118 | -4,263 | -12,373 |
| Other Operating Activity | -989 | 1,032 | -842 | -12,702 | -12,259 |
| Operating Cash Flow | $-9,627 | $-15,294 | $-13,977 | $-25,868 | $-30,218 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -7,525 | N/A | N/A | -1,292 |
| PPE Investments | 318 | 110 | 848 | -988 | -2,327 |
| Net Acquisitions | 2,000 | 569 | 569 | -4,250 | 2,653 |
| Sale Of Investment | 5,024 | 2,502 | N/A | 21,846 | 18,250 |
| Investing Cash Flow | $7,342 | $-4,344 | $1,417 | $16,608 | $17,284 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,108 |
| Debt Repayment | N/A | N/A | N/A | -2,146 | -34 |
| Common Stock Issued | 9 | 6,009 | 5,007 | 25,208 | 17,423 |
| Other Financing Activity | 0 | -497 | -488 | -1,162 | 63 |
| Financing Cash Flow | $9 | $5,512 | $4,519 | $21,900 | $20,560 |
| Exchange Rate Effect | N/A | N/A | N/A | 2 | N/A |
| Beginning Cash Position | 6,518 | 20,644 | 28,685 | 16,043 | 8,417 |
| End Cash Position | 4,242 | 6,518 | 20,644 | 28,685 | 16,043 |
| Net Cash Flow | $-2,276 | $-14,126 | $-8,041 | $12,642 | $7,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,627 | -15,294 | -13,977 | -25,868 | -30,218 |
| Capital Expenditure | -16 | -5 | -72 | -1,007 | -2,335 |
| Free Cash Flow | -9,643 | -15,299 | -14,049 | -26,875 | -32,553 |